Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Taken [CCI] as a Dry Powder via the Nose by Adult Healthy People

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521783-35-00

Acronym

EV-FLU-CL-03

Enrollment

Registered

2025-07-03

Start date

2025-07-10

Completion date

2025-09-23

Last updated

2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza virus

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026